Get Fit Bharat

Tag: Science

HomeScience

Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO:SOBI) announces today that revenue for the full year 2024 was higher than previous estimate. Full-year revenue was approximately SEK 26,000 M, representing approximately 19% growth at constant exchange rate (CER) (1). Adjusted EBITA margin (1,2) was in the mid-30s per cent of revenues.   …

Nordea Bank AbpStock exchange release – Changes in company’s own shares10.01.2025 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 10.01.2025 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading venue (MIC Code) Number of shares Weighted average price / share, EUR* ** Total cost, EUR* ** XHEL …

FIDELITY CHINA SPECIAL SITUATIONS PLC (the 'Company')     TRANSACTION IN OWN SHARES     The Board of the Company announces that it has repurchased for cancellation.     Number of shares repurchased: 248,405 Date of transaction: 10 January 2025 Average share price paid per share (GBp): 213.320 Lowest share price paid per share (GBp): …

FIDELITY JAPAN TRUST PLC (the 'Company')     TRANSACTION IN OWN SHARES     The Board of the Company announces that it has bought into Treasury     Number of shares repurchased: 50,000 Date of transaction: 10 January 2025 Average share price paid per share (GBp): 170.980 Lowest share price paid per share (GBp): 170.500 …

Stockholm, Sweden – January 2025 – SlotsRank, a renowned platform for online slot reviews and rankings, has released its latest insights into branded slot games, a category redefining the online casino landscape. By combining globally recognized franchises with innovative slot mechanics, branded slots have emerged as a favorite among players seeking …

Information about various derivatives that will be listed at NGM. For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, …

Strengthening Competitive Edge and Driving Innovation CS MEDICA announces the achievement of its fourth European patent, this time for its Psoriasis Gel, which is already MDR-approved. This milestone underscores the company’s dedication to delivering innovative, science-backed treatments and further solidifies its competitive edge in the MedTech sector. The patent reinforces …